These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 809069)

  • 1. Immunological overshoot phenomenon following cancer chemotherapy: significance in prognosis evaluation of solid tumors.
    Serrou B; Dubois JB
    Biomedicine; 1975 Feb; 23(1):41-5. PubMed ID: 809069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results].
    Melchert F; Kreienberg R; von Nathusius U
    Fortschr Med; 1980 Feb; 98(8):281-6. PubMed ID: 7380377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].
    Pouillart P; Schwarzenberg L; Amiel JL; Mathé G; Huguenin P; Morin P; Baron A; Laparre Ch; Parrot R
    Nouv Presse Med; 1975 Mar; 4(10):713-6. PubMed ID: 1129034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.
    Gillespie PJ; Alexander JL; Edelstyn GA
    J Nucl Med; 1975 Mar; 16(3):191-3. PubMed ID: 1113166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity reactions in patients with breast cancer.
    Boeva M; Donchev T; Markova R; Christov I
    Neoplasma; 1978; 25(6):733-6. PubMed ID: 752118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidisciplinary curative treatment for disseminated carcinoma of the breast.
    Mannes P; Derriks R; Moens R; Laurent C; Dalcq JM
    Cancer Treat Rep; 1976 Jan; 60(1):85-9. PubMed ID: 1000521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update.
    Glick JH; Fowble BL; Haller DG; Rosato EF; Mackie JA; Weiler C; Glover DJ; Fox KR; Hurwitz S; Goodman RL
    NCI Monogr; 1988; (6):297-301. PubMed ID: 3352774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune reactions in breast cancer patients (author's transl)].
    Sergejew SI; Gorodilowa WW; Baschenowa AP; Mandrik EW; Kasjanow IW
    Arch Geschwulstforsch; 1977; 47(5):421-7. PubMed ID: 412486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.